Tag: china

8 articles

Market Moves

Former Harvard chemistry chair Charles Lieber leads state-funded Shenzhen BCI lab i-BRAIN

Reuters reported on April 30 that Charles Lieber, the former chair of Harvard's chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft's $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.

Apr 30

Market Moves

Axoft raises $55M Series A led by Thailand's C.P. Group Innovation

Cambridge, Massachusetts implantable BCI company Axoft announced an oversubscribed $55M Series A on 29 April, led by Thailand-based C.P. Group Innovation, with Hillhouse Investment, Gaorong Ventures, Alumni Ventures and the Stanford President's Venture Fund. Bloomberg reported the same week that Axoft had tested its brain implant temporarily on four patients in Shanghai, out of 11 tested so far, and planned more work in China this year.

Apr 29

Market Moves

China issues guided pricing for invasive BCI procedures as provinces begin reimbursement roll-out

China's National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.

Apr 23